Education
About Us
Working with TipRanks
Follow Us
TrivarX Limited (AU:TRI)
ASX:TRI
TRI Stock Chart & Stats
AU$0.02
<AU$0.01(6.67%)
At close: 4:00 PM EST
AU$0.02
<AU$0.01(6.67%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.04
Previous CloseN/A
Volume87.40K
Average Volume (3M)1.22M
Market Cap
AU$28.84M
Enterprise ValueAU$27.76M
Total Cash (Recent Filing)AU$1.25M
Total Debt (Recent Filing)AU$169.03K
Price to Earnings (P/E)―
Beta1.95
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding1,153,693,500
10 Day Avg. Volume1,871,965
30 Day Avg. Volume1,217,195
Financial Highlights & Ratios
PEG Ratio0.23
Price to Book (P/B)0.82
Price to Sales (P/S)0.00
P/FCF Ratio-54.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Low Leverage / Strong Balance SheetVery low leverage and a sizeable equity base give durable financial flexibility. This reduces insolvency and refinancing risk, supports continued R&D or product development during loss-making periods, and lengthens runway, enabling strategic options without immediate debt pressure.
Improving Cash Outflow TrendA marked reduction in free cash outflow from 2024 to 2025 indicates improving cash discipline and lower burn. If sustained, this durable trend extends runway, lowers near-term financing needs, and increases the probability management can invest toward commercialisation and break-even.
Exposure To Healthcare IT Industry TailwindsOperating in Medical - Healthcare Information Services aligns the company with structural demand for health IT and data solutions. Enduring industry digitisation and regulatory reporting needs create a long-term addressable market that can support sustainable growth if product-market fit is achieved.
Bears Say
No Reported RevenueAbsence of reported revenue across the provided periods is a fundamental weakness: it prevents validation of product-market fit, blocks margin scaling, and means future profitability depends on successful monetisation and customer acquisition, raising execution risk.
Sustained Net Losses And Negative Operating ProfitConsecutive annual losses and a sizable operating loss show the business is not yet profitable. Persistent negative earnings erode equity, increase funding needs, and may force dilution or constrain investments, making long-term viability dependent on reversing this trend.
Negative Operating And Free Cash FlowOngoing negative operating and free cash flows indicate the company consumes cash rather than generates it. This structural cash burn necessitates external financing to sustain operations, limits strategic flexibility, and elevates execution and liquidity risk until cash generation turns positive.
TrivarX Limited News
TRI FAQ
What was TrivarX Limited’s price range in the past 12 months?
TrivarX Limited lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is TrivarX Limited’s market cap?
TrivarX Limited’s market cap is AU$28.84M.
When is TrivarX Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were TrivarX Limited’s earnings last quarter?
Currently, no data Available
Is TrivarX Limited overvalued?
According to Wall Street analysts TrivarX Limited’s price is currently Overvalued.
Does TrivarX Limited pay dividends?
TrivarX Limited does not currently pay dividends.
What is TrivarX Limited’s EPS estimate?
TrivarX Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does TrivarX Limited have?
TrivarX Limited has 1,153,693,500 shares outstanding.
What happened to TrivarX Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of TrivarX Limited?
Currently, no hedge funds are holding shares in AU:TRI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
TrivarX Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:TRI Sentiment 70%
Sector Average ―
Sector Average ―
Insider Transactions
Bought Shares
Worth AU$140.0K over
the Last 3 Months
the Last 3 Months
Fundamentals
Return on Equity
-8.06%
Trailing 12-Months
Asset Growth
19.55%
Trailing 12-Months
Company Description
TrivarX Limited
TrivarX Limited, a health technology company, engages in the development of AI-driven, scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. The company offers mental well-being solutions for businesses through corporate health product; and develops products for healthcare provider market. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Mount Lawley, Australia.
Technical Analysis
Tali Digital
―
Global Health Limited
―
Opyl Ltd.
―
HitIQ Limited
―
InteliCare Holdings Limited
―
Options Prices
Currently, No data available
---